Praxis Precision Medicines (PRAX) - Cash Funds Calculated per Share

Praxis Precision Medicines - graphic logo of issuer PRAX

Praxis Precision Medicines focuses on rare genetic forms of epilepsy to achieve accelerated therapy approval. Cash per share for Praxis Precision Medicines demonstrates an upward trend, where 26.64 shows the level of this metric. Financial stability is based on the experienced management's ability to attract venture capital and the use of personal genetic data to minimize scientific risks when developing targeted drugs.

Praxis Medicines (PRAX) Cash per Share: for the period 07/04/2022 - 11/20/2026

Analytical breakdowns for Praxis Precision Medicines

- stock value and consensus price forecast:
- cash availability and cash flow indicators:
General company analysis:Praxis Corp - PRAX
Original product of Praxis Precision Medicines Inc

This multiple allows for the determination of an asset's intrinsic value by comparing liquid reserves with the number of shares to assess the business's financial autonomy. By analyzing the amount of free cash per share, an investor can see the real margin of safety for Praxis Precision Medicines (PRAX) to fund the costly development of precision drugs against resistant forms of epilepsy, which is critically important for biotech companies in the R&D stage.

Analysis of competing companies

Biogen Corp (BIIB) - Cash Funds Calculated per Share|Cash per Share NBIX|RGC - Cash on Hand per Share|Cash Funds per Share Axsome Therapeutics AXSM|Cash per Share ACADIA Pharmaceuticals Inc. ACAD|xenon-pharma.com - Cash per Share|Cash on Hand per Share Viking Therapeutics|SUPN: Cash per Share|Catalyst Pharmaceuticals (CPRX) - Cash per Share|Cash per Single Share DNLI|Cash Funds per Single Share HRMY (Harmony Biosciences Holdings, Inc.)|Cash Funds per Share Biohaven Ltd. (BHVN)|Cash Calculated per Single Share AMLX|Cash Funds per Share trevitherapeutics.com TRVI|AVXL - Cash per Single Share|CeriBell EEG - Cash per Share|Cash on Hand per Share prothena.com|Alector Therapeutics (ALEC) - Cash Funds per Share|Annexon Biosciences Inc. - Amount of Cash per Share|OMER (Omeros Corp) - Cash per Share|Cash per Share neurogene.com|Cash per Share ACIU|VYGR - Cash on Hand per Share|Cash Funds per Share Neumora Therapeutics Inc NMRA|Cash Funds Calculated per Share Scilex Holding Co. (SCLX)|TVGN - Cash Funds per Share|Cash on Hand per Share alphacognition.com|CGTX (Cognition Therapeutics, Inc.) - Cash per Single Share|IKT: Cash Calculated per Single Share|Cash Funds per Share Cassava Sciences, Inc.|ASRT (assertiotx.com) - Cash Calculated per Single Share|Cash Funds per Share Coya (COYA)|VTGN - Cash on Hand per Share|Cash per Share OVID (Ovid Therapeutics)|Acumen Pharma (ABOS) - Cash on Hand per Share|cervomed.com - Cash per Share|Amount of Cash per Share ATHE (Alterity Therapeutics Limited)|CLNN: Cash per Share|Cash per Single Share PepGen Inc.|JUNS (Jupiter Neurosciences, Inc.) - Cash per Share|Cash on Hand per Share Relmada Therapeutics Inc RLMD|Cash Funds per Share Annovis Bio Corporation (ANVS)|GRCE - Cash on Hand per Share|Cash Funds per Share Firefly Neuroscience, Inc. AIFF|Klotho Neurosciences Inc (KLTO) - Cash on Hand per Share|NeuroSense Therapeutics, Ltd. - Cash per Share|RVPH: Cash Funds per Share|MTVA: Cash per Share|NRXS - Cash Funds Calculated per Share|HSDT (Helius Medical Technologies Inc.) - Cash per Share|Cash on Hand per Share Passage Bio PASG|Cash Funds per Share Neuphoria (NEUP)|Cash per Share Minerva Neurosciences Corp (NERV)|Cash Funds per Share Athira ATHA|Cash per Share Addex ADXN|Alzamend - Cash per Share|Cash on Hand per Share Cyclerion Therapeutics, Inc.|Protagenic Therapeutics (PTIX) - Cash Funds per Share|KTTA: Cash Calculated per Single Share|Cash per Single Share CRGT|Avenue Therapeutics, Inc - Cash Money per Share|Cash Funds per Share Brainstorm Cell (BCLI)|CARA: Cash Money per Share|Chromocell Therapeutics Corp. - Cash per Single Share|Cash Funds Calculated per Share Eliem (ELYM)|ITCI: Cash per Single Share|Amount of Cash per Share LBPH (Longboard)|marinuspharma.com (MRNS) - Cash Funds per Share|NKGN - Cash Funds Calculated per Share|NRBO (neurobopharma.com) - Cash per Share|Sage Therapeutics (SAGE) - Cash Funds Calculated per Share|Cash per Single Share SNPX (Synaptogenix, Inc.)|TRVN - Cash on Hand per Share|Cash per Share VIGL (Vigil Neuro)|WENA: Cash Funds per Single Share|CERE - Cash Funds per Share